Table 1 Cuban patients studied (n = 104), according to their genotype for the TaqI polymorphism of the VDR gene and the possibility of a clinical form -whether non symptomatic or symptomatic- compared to the risk of presenting another clinical forms
| Clinical forms | Genotypes for the TaqI polymorphism | |||||
|---|---|---|---|---|---|---|
| tt | Tt | TT | ||||
| No | OR (IC = 95%) | No | OR (IC = 95%) | No | OR (IC = 95%) | |
| Symptomatic (n = 81) | 7 |
2.081 [0.243–17.842] | 34 |
0.465 [0.180–1.198] | 40 |
1.829 [0.699–4.788] |
| Non symptomatic (n = 23) | 1 |
0.481 [0.056–4.120] | 14 |
2.150 [0.835–5.541] | 8 |
0.547 [0.209–1.431] |